357 related articles for article (PubMed ID: 36544907)
1. A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers.
Xu J; Wang X; Zhu C; Wang K
Front Cell Dev Biol; 2022; 10():997633. PubMed ID: 36544907
[TBL] [Abstract][Full Text] [Related]
2. Potential applications of MEG3 in cancer diagnosis and prognosis.
He Y; Luo Y; Liang B; Ye L; Lu G; He W
Oncotarget; 2017 Sep; 8(42):73282-73295. PubMed ID: 29069869
[TBL] [Abstract][Full Text] [Related]
3. MEG3 noncoding RNA: a tumor suppressor.
Zhou Y; Zhang X; Klibanski A
J Mol Endocrinol; 2012 Jun; 48(3):R45-53. PubMed ID: 22393162
[TBL] [Abstract][Full Text] [Related]
4. Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA.
Ghafouri-Fard S; Taheri M
Biomed Pharmacother; 2019 Oct; 118():109129. PubMed ID: 31326791
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of mRNA-lncRNA co-expression profile revealing crucial role of imprinted gene cluster DLK1-MEG3 in chordoma.
Chen H; Zhang K; Lu J; Wu G; Yang H; Chen K
Oncotarget; 2017 Dec; 8(68):112623-112635. PubMed ID: 29348851
[TBL] [Abstract][Full Text] [Related]
6. The Biological Roles and Molecular Mechanisms of Long Non-Coding RNA MEG3 in the Hallmarks of Cancer.
Zhang L; Zhao F; Li W; Song G; Kasim V; Wu S
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551518
[TBL] [Abstract][Full Text] [Related]
7. Deregulated expression of the imprinted DLK1-DIO3 region in glioblastoma stemlike cells: tumor suppressor role of lncRNA MEG3.
Buccarelli M; Lulli V; Giuliani A; Signore M; Martini M; D'Alessandris QG; Giannetti S; Novelli A; Ilari R; Giurato G; Boe A; Castellani G; Spartano S; Marangi G; Biffoni M; Genuardi M; Pallini R; Marziali G; Ricci-Vitiani L
Neuro Oncol; 2020 Dec; 22(12):1771-1784. PubMed ID: 32459347
[TBL] [Abstract][Full Text] [Related]
8. Functional impact of the long non-coding RNA
Deocesano-Pereira C; Machado RAC; De Jesus-Ferreira HC; Marchini T; Pereira TF; Carreira ACO; Sogayar MC
Oncol Lett; 2019 Dec; 18(6):5941-5951. PubMed ID: 31788068
[TBL] [Abstract][Full Text] [Related]
9.
Yen YP; Hsieh WF; Tsai YY; Lu YL; Liau ES; Hsu HC; Chen YC; Liu TC; Chang M; Li J; Lin SP; Hung JH; Chen JA
Elife; 2018 Oct; 7():. PubMed ID: 30311912
[TBL] [Abstract][Full Text] [Related]
10. Expression of ncRNAs on the DLK1-DIO3 Locus Is Associated With Basal and Mesenchymal Phenotype in Breast Epithelial Progenitor Cells.
Budkova Z; Sigurdardottir AK; Briem E; Bergthorsson JT; Sigurdsson S; Magnusson MK; Traustadottir GA; Gudjonsson T; Hilmarsdottir B
Front Cell Dev Biol; 2020; 8():461. PubMed ID: 32612992
[TBL] [Abstract][Full Text] [Related]
11. The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells.
Tao Y; Yue P; Miao Y; Gao S; Wang B; Leng SX; Meng X; Zhang H
J Gene Med; 2021 Feb; 23(2):e3291. PubMed ID: 33141998
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Long Non-Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA-664.
He JH; Han ZP; Liu JM; Zhou JB; Zou MX; Lv YB; Li YG; Cao MR
J Cell Biochem; 2017 Nov; 118(11):3713-3721. PubMed ID: 28374914
[TBL] [Abstract][Full Text] [Related]
13. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
Wang X; Li X; Wang Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
[TBL] [Abstract][Full Text] [Related]
14. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.
Al-Rugeebah A; Alanazi M; Parine NR
Pathol Oncol Res; 2019 Jul; 25(3):859-874. PubMed ID: 30793226
[TBL] [Abstract][Full Text] [Related]
15. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression.
Zhang X; Gejman R; Mahta A; Zhong Y; Rice KA; Zhou Y; Cheunsuchon P; Louis DN; Klibanski A
Cancer Res; 2010 Mar; 70(6):2350-8. PubMed ID: 20179190
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4.
Ning J; Zhang L; Guo H; Zhou S; Sun X; Bao W
Transl Cancer Res; 2020 Feb; 9(2):958-971. PubMed ID: 35117441
[TBL] [Abstract][Full Text] [Related]
17. Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines.
Mo CF; Wu FC; Tai KY; Chang WC; Chang KW; Kuo HC; Ho HN; Chen HF; Lin SP
Stem Cell Res Ther; 2015 Jan; 6(1):1. PubMed ID: 25559585
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA MEG3 in Metal Carcinogenesis.
Zhang Z; Shi S; Li J; Costa M
Toxics; 2023 Feb; 11(2):. PubMed ID: 36851033
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.
Zhang J; Yao T; Wang Y; Yu J; Liu Y; Lin Z
Cancer Biol Ther; 2016; 17(1):104-13. PubMed ID: 26574780
[TBL] [Abstract][Full Text] [Related]
20. Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma.
Greife A; Knievel J; Ribarska T; Niegisch G; Schulz WA
Clin Epigenetics; 2014; 6(1):29. PubMed ID: 25741387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
